Antibodies against recombinant Ro 60 Kd, Ro52 Kd and La 48 Kd proteins in primary Sjögren's Syndrome;Anticuerpos a proteínas recombinantes Ro60 Kd, Ro52 Kd y La48 Kd, en el síndrome de Sjögren primario. Utilidad de la combinación de métodos analíticos para detectar anticuerpos anti Ro y anti La

Revista Medica de Chile

Volumn 130, Issue 8, 2002, Pages 841-849

  Aguilera C, Sergio ^b   González B, María Julieta ^a   Pérez R, Paola ^a   Castillo A, Darwin ^b   Gatica R, Héctor ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b Hospital Exequiel González Cortés   (Chile)

^c Reumatólogo Clin Indisa ^*

Author keywords

Antibody specificity; Recombinant proteins; Sj gren syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIGEN; BACTERIUM ANTIBODY; RIBONUCLEOPROTEIN; SMALL CYTOPLASMIC RNA; SS A ANTIGEN; SS-A ANTIGEN; SSA2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; IMMUNOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, BACTERIAL; AUTOANTIGENS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMANS; MIDDLE AGED; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME;

EID: 0036689846     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. TALAL N, MOUTSOPOULOS HM, KASSAN SS, Eds. Sjögren's syndrome. Clinical and immunological aspects. Springer Verlag Berlin 1987. ISBN: 3-540-174777-X.
2. FOX RI, SAITO I. Criteria for diagnosis of Sjögren's syndrome. Rheum Dis Clin North Am 1994; 2: 391-407.
3. TALAL N. Sjögren's syndrome: Historical overview and clinical spectrum of disease. Rheum Dis Clin North Am 1992; 18: 507-15.
4. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM, COLL J, GERLI R, HATRON PY ET AL. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996; 55: 116-21.
5. VITALI C, BOMBARDIERI S AND EUROPEAN STUDY GROUP ON DIAGNOSTIC CRITERIA FOR SS. The European classification criteria for Sjögren's syndrome (SS). Proposal for modification of the rules for classification suggested by the analysis of the receiver operating characteristic (ROCS) curve of the criteria performance. J Rheum 1997; 24 (Suppl): S18.
6. FOX RI. Sjögren's syndrome. Controversies and progress. Clinics Lab Med 1997; 17: 431-44.
7. FOX RI, TORNWALL J, MURAYAMA T, STERN M. Evolving concepts of diagnosis, pathogenesis and therapy of Sjögren's syndrome. Curr Opin Rheumatol 1998; 10: 446-56.
8. MCCAULIFFE DP, WANG L, SATOH M, REEVES WH, SMALL D. Recombinant 52 Kd Ro (SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays. J Rheum 1997; 24: 860-6.
9. MCCAULIFFE DP, YIN H, WANG LX, LUCAS L. Autoimmune sera react with multiple epitopes on recombinant 52 and 60 Kda Ro (SSA) proteins. J Rheumatol 1994; 21: 1073-80.
10. MEHEUS L, VAN VENROOIJ WJ, WIIK A, CHARLES PJ, TZIOUFAS AG, MEYER O ET AL. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheum 1999; 17: 205-14.
11. SCOFIELD RH, FARRIS AD, HORSFALL AC, HARLEY J. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. Arthritis Rheum 1999; 42: 199-209.
12. SÁNCHEZ-GUERRERO J, LEW RA, FOSSEL A, SCHUR P. Utility of anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis Rheum 1996; 39: 1055-61.
13. REICHLIN M, SCOFIELD RH. SS-A (Ro) autoantibodies. In: Peter JB, Schoenfeld Y, eds.: Autoantibodies, Amsterdam: Elsevier 1996; 783-8.
14. KEECH CL, MC CLUSKEY J, GORDON TP. SS-B (La) autoantibodies. In: Peter JB, Schoenfeld Y eds.: Autoantibodies, Amsterdam: Elsevier 1996; 783-8.
15. YAMAMOTO AM, AMOURA Z, JOHANNET C, JERÓNIMO AL, CAMPOS H, KOUTOUZOV S ET AL. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases. Arthritis Rheum 2000; 43: 689-98.
16. FRANK MB, MC CUBBIN VR, HELDERMON C. Expression and DNA binding of the human 52-Kd Ro/SSA autoantigen. Biochem J 1995; 305: 359-62.
17. Workshop on diagnostic criteria for Sjögren's syndrome. I. Questionnaires for dry eye and dry mouth. II. Manual of methods and procedures. Clin Exp Rheumatol 1989; 7: 211-9.
18. VITALI C, MOUTSOPOULOS HM, BOMBARDIERI S, EUROPEAN STUDY GROUP ON DIAGNOSTIC CRITERIA FOR SJÖGREN'S SYNDROME. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 1994; 53: 637-47.
19. ISHIKAWA E. Development and clinical applications of sensitive enzyme immunoassays for macromolecular antigens-a rewiew. Clin Biochem 1987; 20: 375-85.
20. KELLY CA, FOSTER H, PAL B, GARDINER P, MALCOLM AJ, CHARLES P ET AL. Primary Sjögren's syndrome in North East of England. A longitudinal study. Br J Rheumatol 1991; 30: 437-42.
21. PEASE CT, CHARLES PJ, SHATTLES W, MARKWICK J, MAINI RN. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome. Br J Rheumatol 1993; 32: 574-7.
22. DAVIDSON BKS, KELLY CA, GRIFFITHS ID. Primary Sjögren's syndrome in North East of England: a long term follow-up study. Rheumatology 1999; 38: 245-53.
23. TENGNÉR P, HAEISE A-K, HAGA H-J, JONSSON R, WAHREN-HERLENIUS M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 1998; 41: 2238-48.
24. ELAGIB KEE, TENGNÉR P, LEVI M, JONSSON K, THOMPSON KM, NATVIG JB, WAHREN-HERLENIUS M. Immunoglobulin variable genes and epitope recognition of human monoclonal ami-Ro 52-Kd in primary Sjögren's syndrome. Arthritis Rheum 1999; 42: 2471-81.
25. WALTER SD. Methods of reporting statistical results from medical research studies. Am J Epidem 1995; 141: 896-906.
26. KRAMER MS, FEINSTEIN AR. Clinical biostatistics LIV. The biostatistics of concordance. Clin Pharmacol Ther 1981; 29: 111-23.
27. O'BRIAN CA, WOLIN SL. A possible role for the 60-KD Ro autoantigen in a discard pathway for defective 5S RNA precursors. Gene Develop 1994; 8: 2891-903.
28. HUANG S-C, SCOFIELD RH, KURIEN BT, HARLEY JB. Human anti-Ro autoantibodies bind multiple conformational epitopes of 60-kD Ro autoantigen. J Clin Immunol 1997; 17: 212-9.
29. WAHREN M, RUDÉN U, ANDERSSON B, RINGERTZ NR, PETTERSSON Y. Identification of antigenic regions of the human Ro 60kDa protein using recombinant antigen and synthetic peptides. J Autoimmun 1992; 5: 319-32.
30. JAMES JA, DICKEY WD, FUJISAKU A, O'BRIEN CA, DEUTSCHER SL, KEENE JD ET AL. Antigenicity of a recombinant Ro (SS-A) fusion protein. Arthritis Rheum 1990; 33: 102-6.
31. BOIRE G, GENDRON M, MONAST N, BASTIN B, MENARD HA. Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 1995; 100: 489-98.
32. KELEKAR A, SAITTA MR, KEENE JD. Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60-and 52-KD proteins. J Clin Invest 1994; 92: 1637-44.
33. CHENG ST, NGUYEN TQ, YANG YS, CAPRA JD, SONTHEIMER RD. Calreticulin binds hY RNA and the 52-kDa polypeptide component of the Ro SS-A ribonucleoprotein autoantigen. J Immunol 1996; 156: 4484-91.
34. ITOH Y, REICHLIN M. Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti 52 kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992; 14: 57-65.
35. POURMAND N, PETTERSSON I. The Zn++ binding domain of the human Ro 52 Kda protein is a target for conformation-dependent autoantibodies. J Autoimmun 1998; 11: 11-7.
36. BOIRE G, CRAFT J. Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J Clin Invest 1990; 85: 1182-90.
37. Yoo CL, WOLIN SL. The yeast La protein is required for the 3′ endonucleolytic cleavage that nature tRTNA precursors. Cell 1997; 89: 393-402.
38. WILLIAMS DG, STOCKS MR, CHARLES PJ, MAINI RN. Antibodies to La, Jo-1, n RNP and Sm detected by multi-track immunoblotting using a novel filter holder: A comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Immunol Methods 1986; 91: 65-73.
39. EMLEN W, O'NEILL L. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme linked immunosorbent assays. Arthritis Rheum 1997; 40: 1612-8.
40. TAN EM, SMOLEN JS, MCDOUGAL JS, BUTCHER BT, CONN D, DAWKINS R ET AL. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. Precision, sensitivity and specificity. Arthritis Rheum 1999; 42: 455-64.
41. FOX RI, STERN M, MICHELSON P. Update in Sjögren's Syndrome. Curr Opin Rheum 2000; 391-8.
42. GUNAIDIN I, TERHORST T, ECKSTEIN A. Assessment of Keratoconjunctivitis sicca in patients with fibromyalgia: results of a prospective study. Rheumatol Int 1999; 19: 7-9.
43. BUYON JP, SLADE SG, REVEILLE JD, HAMEL JC, CHAN EKL. Autoantibody responses to the native 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjögren's syndrome. J Immunol 1994; 152: 3675-84.
44. MIRANDA-CARÚS ME, TSENG CE, RASHBAUM W, OCHS RL, CASIANO CA, DIDONATO F ET AL. Accessibility of SS-A/Ro and SS-B/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 1998; 161: 5061-9.
45. ANAYA JM, TALAL N. Sjögren's syndrome comes of age. Sem Arthritis Rheum 1999; 28: 355-9.
46. PÉREZ P, GOICOVICH E, ALLIENDE C, AGUILERA S, LEYTON C, MOLINA C ET AL. Differential expression of gelatinases A/MMP-2, B/MMP-9 and stromelysin 1/MMP-3 in labial salivary glands of patients with primary Sjögren's syndrome: Exocrine parenchyme destruction mechanism. Arthritis Rheum 2000; 43: 2807-17.
47. TSENG C-E, CHAN EKL, MIRANDA E, GROSS M, DI DONATO F, BUYON JP. The 52-Kd protein as a target of intermolecular spreading of immune response to components of the SS-A/Ro-SS-B/La complex. Arthritis Rheum 1997; 40: 936-44.
48. BACMAN S, STERIN-BORDA, CAMUSSO JJ, ARANA R, HUBSCHER O, BORDA E. Circulating antibodies against rat parotid gland M3 muscarinic receptor in primary Sjögren's syndrome. Clin Exp Imm 1996; 104: 454-9.
49. WITTE T, MATHIAS T, ARNETT FC, PETER HH, HARTUNG K, SAACHSE C ET AL. IgA and IgG autoantibodies against α-fodrin asa markers for Sjögren's syndrome. J Rheumatol 2000; 27: 2017-20.
50. BUYON JP, TSENG CE, DI DONATO F, RASHBAUM W, MORRIS A, CHAN EKL. Cardiac expression of 52 ß an alternative transcript of the congenital heart block-associated 52-KD SS-A/Ro autoantigen, is maximal during fetal development. Arthritis Rheum 1997; 40: 655-60.
51. GERLI R, MUSCAT C, GIANSANTI M, DANIELI MG, SCIUTO M, GABRIELLI A ET AL. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: Its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol 1997; 969-75.